Finance

Lists
688513:SHA
Chengdu Easton Biopharmaceuticals Co Ltd
45,39 CN¥
-1,33%
(-0,61) 1D
16 қаз., 15:00:00 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688513...
Open
46,49 CN¥
High
48,45 CN¥
Low
45,18 CN¥
Mkt. cap
8,12 млрд
Avg. vol.
1,91 млн
Volume
2,01 млн
Dividend
1,08%
Quarterly dividend
0,12 CN¥
Ex-dividend date
2026 ж. 02 мау.
P/E ratio
28,35
52-wk high
80,48 CN¥
52-wk low
40,25 CN¥
EPS
1,60 CN¥
No. of employees
1 мың
Open
46,49 CN¥
High
48,45 CN¥
Low
45,18 CN¥
Mkt. cap
8,12 млрд
Avg. vol.
1,91 млн
Volume
2,01 млн
Dividend
1,08%
Quarterly dividend
0,12 CN¥
Ex-dividend date
2026 ж. 02 мау.
P/E ratio
28,35
52-wk high
80,48 CN¥
52-wk low
40,25 CN¥
EPS
1,60 CN¥
No. of employees
1 мың
News stories
From web sources and news partners
About Chengdu Easton Biopharmaceuticals Co Ltd
CEO-
Employees1,42 мың
Founded2009 ж. 01 мау.
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
364,69 млн
312,26 млн
326,26 млн
332,64 млн
Cost of goods sold
87,18 млн
88,47 млн
73,62 млн
82,94 млн
Cost of revenue
87,18 млн
88,47 млн
73,62 млн
82,94 млн
Research and development expenses
54,95 млн
79,44 млн
72,66 млн
77,99 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
136,71 млн
128,80 млн
143,86 млн
107,14 млн
Operating expense
197,59 млн
214,09 млн
212,02 млн
195,99 млн
Total operating expenses
284,77 млн
302,56 млн
285,64 млн
278,93 млн
Operating income
79,91 млн
9,70 млн
40,62 млн
53,71 млн
Other non operating income
-228,90 м.
230,85 м.
-519,09 м.
493,27 м.
EBT including unusual items
92,35 млн
57,56 млн
47,40 млн
86,84 млн
EBT excluding unusual items
79,77 млн
51,53 млн
41,48 млн
54,72 млн
Income tax expense
8,76 млн
4,15 млн
4,12 млн
18,02 млн
Effective tax rate
9,49%
7,21%
8,69%
20,75%
Other operating expenses
4,49 млн
8,00 млн
-4,46 млн
11,52 млн
Net income
83,59 млн
63,90 млн
50,83 млн
78,92 млн
Net profit margin
22,92%
20,46%
15,58%
23,73%
Earnings per share
-
-
-
-
Interest and investment income
733,65 м.
42,65 млн
1,95 млн
2,46 млн
Interest expense
-615,69 м.
-622,07 м.
-575,93 м.
-792,69 м.
Net interest expenses
117,96 м.
42,02 млн
1,38 млн
1,67 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
100,25 млн
32,44 млн
63,37 млн
81,43 млн
Gain or loss from assets sale
-
-29,35 мың
-
-18,53 мың
AI content may include mistakes. Learn more
Google қолданбалары